You are here
Focus on increased low adherence in any oral cancer treatment
Interview with Andrea Antonuzzo, MD, recorded at ESMO, September 2014.
Adherence is a big problem in oral cancer therapy because low adherence leads to low efficacy, bad outcomes and bad quality of life. Dr. Andrea Antonuzzo sketches the reasons for bad adherence and what can be done to improve it. Further topics: the differences between patient care in clinical studies and the real-world clinical practice and why there is a need for trials with unselected patients and for more prospective studies with Quality of Life evaluation for new drugs, due to an increasing number of fast drug approvals where the toxicities are not very well known.
Andrea Antonuzzo, MD, is Head of Supportive Care Unit, Medical Oncology 1, at Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.